These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1530 related items for PubMed ID: 16285233

  • 1. Immunoblot studies in allergic patients to hymenoptera venom before and during immunotherapy.
    Pereira Santos MC, Pedro E, Spínola Santos A, Branco Ferreira M, Palma Carlos ML, Palma Carlos AG.
    Eur Ann Allergy Clin Immunol; 2005 Sep; 37(7):273-8. PubMed ID: 16285233
    [Abstract] [Full Text] [Related]

  • 2. Expansion of circulating Foxp3+)D25bright CD4+ T cells during specific venom immunotherapy.
    Pereira-Santos MC, Baptista AP, Melo A, Alves RR, Soares RS, Pedro E, Pereira-Barbosa M, Victorino RM, Sousa AE.
    Clin Exp Allergy; 2008 Feb; 38(2):291-7. PubMed ID: 18070166
    [Abstract] [Full Text] [Related]

  • 3. Patients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased venom doses.
    Ruëff F, Wenderoth A, Przybilla B.
    J Allergy Clin Immunol; 2001 Dec; 108(6):1027-32. PubMed ID: 11742283
    [Abstract] [Full Text] [Related]

  • 4. Hymenoptera sting anaphylaxis: detection and clinical significance of individual bee and wasp venoms specific IgE and IgG4 antibodies.
    Ameno S, Ameno K, Fuke C, Shinohara T, Kiriu T, Kinoshita H, Ijiri I.
    Nihon Hoigaku Zasshi; 1993 Jun; 47(3):207-12. PubMed ID: 8345683
    [Abstract] [Full Text] [Related]

  • 5. Humoral immunological response in patients with venom allergy during specific immunotherapy.
    Szymański W, Chyrek-Borowska S.
    Rocz Akad Med Bialymst; 1995 Jun; 40(2):376-82. PubMed ID: 8834621
    [Abstract] [Full Text] [Related]

  • 6. Natural history of Hymenoptera venom allergy in Eastern Spain.
    Fernandez J, Soriano V, Mayorga L, Mayor M.
    Clin Exp Allergy; 2005 Feb; 35(2):179-85. PubMed ID: 15725189
    [Abstract] [Full Text] [Related]

  • 7. Serum concentration of baseline mast cell tryptase: evidence for a decline during long-term immunotherapy for Hymenoptera venom allergy.
    Dugas-Breit S, Przybilla B, Dugas M, Arnold A, Pfundstein G, Küchenhoff H, Ruëff F.
    Clin Exp Allergy; 2010 Apr; 40(4):643-9. PubMed ID: 20100187
    [Abstract] [Full Text] [Related]

  • 8. Development of new IgE specificities to hymenoptera allergens during venom-specific immunotherapy.
    Tavares B, Rordigues F, Pereira C, Loureiro G, Chieira C.
    Eur Ann Allergy Clin Immunol; 2005 May; 37(5):171-6. PubMed ID: 15984315
    [Abstract] [Full Text] [Related]

  • 9. Rush hymenoptera venom immunotherapy is efficacious and safe.
    Pasaoglu G, Sin BA, Misirligil Z.
    J Investig Allergol Clin Immunol; 2006 May; 16(4):232-8. PubMed ID: 16889280
    [Abstract] [Full Text] [Related]

  • 10. Hymenoptera venom allergy.
    Przybilla B, Ruëff F.
    J Dtsch Dermatol Ges; 2010 Feb; 8(2):114-27; quiz 128-30. PubMed ID: 19751222
    [Abstract] [Full Text] [Related]

  • 11. Outcome survey of insect venom allergic patients with venom immunotherapy in a rural population.
    Roesch A, Boerzsoenyi J, Babilas P, Landthaler M, Szeimies RM.
    J Dtsch Dermatol Ges; 2008 Apr; 6(4):292-7. PubMed ID: 18042250
    [Abstract] [Full Text] [Related]

  • 12. Safety of specific immunotherapy using a four-hour ultra-rush induction scheme in bee and wasp allergy.
    Roll A, Hofbauer G, Ballmer-Weber BK, Schmid-Grendelmeier P.
    J Investig Allergol Clin Immunol; 2006 Apr; 16(2):79-85. PubMed ID: 16689180
    [Abstract] [Full Text] [Related]

  • 13. Specific ultrarush desensitization in Hymenoptera venom-allergic patients.
    Schiavino D, Nucera E, Pollastrini E, De Pasquale T, Buonomo A, Bartolozzi F, Lombardo C, Roncallo C, Patriarca G.
    Ann Allergy Asthma Immunol; 2004 Apr; 92(4):409-13. PubMed ID: 15104191
    [Abstract] [Full Text] [Related]

  • 14. Three days rush venom immunotherapy in bee allergy: safe, inexpensive and instantaneously effective.
    Goldberg A, Yogev A, Confino-Cohen R.
    Int Arch Allergy Immunol; 2011 Apr; 156(1):90-8. PubMed ID: 21447964
    [Abstract] [Full Text] [Related]

  • 15. Long-term protection after stopping venom immunotherapy: results of re-stings in 200 patients.
    Lerch E, Müller UR.
    J Allergy Clin Immunol; 1998 May; 101(5):606-12. PubMed ID: 9600496
    [Abstract] [Full Text] [Related]

  • 16. Prevalence and clinical relevance of specific immunoglobulin E to pollen caused by sting- induced specific immunoglobulin E to cross-reacting carbohydrate determinants in Hymenoptera venoms.
    Kochuyt AM, Van Hoeyveld EM, Stevens EA.
    Clin Exp Allergy; 2005 Apr; 35(4):441-7. PubMed ID: 15836751
    [Abstract] [Full Text] [Related]

  • 17. [Immunotherapy against hymenoptera venom: report of ten patients].
    Guzmán M MA, Salinas L J, Toche P P, Marinovic M MA, Gallardo O AM.
    Rev Med Chil; 2007 Dec; 135(12):1566-71. PubMed ID: 18357358
    [Abstract] [Full Text] [Related]

  • 18. Safety of angiotensin-converting enzyme inhibitors while receiving venom immunotherapy.
    White KM, England RW.
    Ann Allergy Asthma Immunol; 2008 Oct; 101(4):426-30. PubMed ID: 18939733
    [Abstract] [Full Text] [Related]

  • 19. Diagnosis of Hymenoptera venom allergy.
    Biló BM, Rueff F, Mosbech H, Bonifazi F, Oude-Elberink JN, EAACI Interest Group on Insect Venom Hypersensitivity.
    Allergy; 2005 Nov; 60(11):1339-49. PubMed ID: 16197464
    [Abstract] [Full Text] [Related]

  • 20. Deliberate hymenoptera sting challenge as a diagnostic tool in highly selected venom-allergic patients.
    Goldberg A, Confino-Cohen R, Mekori YA.
    Ann Allergy Asthma Immunol; 1995 Jul; 75(1):30-2. PubMed ID: 7621057
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 77.